Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015 (2015), Article ID 170987, 7 pages
http://dx.doi.org/10.1155/2015/170987
Research Article

Association among Fibrinolytic Proteins, Metabolic Syndrome Components, Insulin Secretion, and Resistance in Schoolchildren

1Division of Nephrology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan
2Division of Endocrinology and Metabolism, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan
3Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan
4Taitung Hospital, Ministry of Health and Welfare, Taitung County 95043, Taiwan
5School of Public Health, National Defense Medical Center, Taipei 11490, Taiwan
6School of Pharmacy, National Defense Medical Center, Taipei 11490, Taiwan
7Division of Endocrinology and Metabolism, Department of Internal Medicine, Cardinal Tien Hospital, Xindian, New Taipei City 23148, Taiwan
8Medical School, Catholic Fu Jen University, New Taipei City 24205, Taiwan
9Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan
10Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan

Received 21 July 2015; Accepted 12 October 2015

Academic Editor: Donatella Capalbo

Copyright © 2015 Jin-Shuen Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Kaur, “A comprehensive review on metabolic syndrome,” Cardiology Research and Practice, vol. 2014, Article ID 943162, 21 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. G. S. Berenson, M. Agirbasli, Q. M. Nguyen, W. Chen, and S. R. Srinivasan, “Glycemic status, metabolic syndrome, and cardiovascular risk in children,” Medical Clinics of North America, vol. 95, no. 2, pp. 409–417, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Plesner, N. Behrendt, and M. Ploug, “Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR,” Stem Cells, vol. 15, no. 6, pp. 398–408, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. P. E. P. Dekkers, T. ten Hove, A. A. te Velde, S. J. H. van Deventer, and T. van der Poll, “Upregulation of monocyte urokinase plasminogen activator receptor during human endotoxemia,” Infection and Immunity, vol. 68, no. 4, pp. 2156–2160, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. M. R. Gyetko, E. A. Libre, J. A. Fuller, G.-H. Chen, and G. B. Toews, “Urokinase is required for T lymphocyte proliferation and activation in vitro,” Journal of Laboratory and Clinical Medicine, vol. 133, no. 3, pp. 274–288, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Nykjær, B. Møller, R. F. Todd III et al., “Urokinase receptor. An activation antigen in human T lymphocytes,” The Journal of Immunology, vol. 152, no. 2, pp. 505–516, 1994. View at Google Scholar · View at Scopus
  7. A. Mondino and F. Blasi, “uPA and uPAR in fibrinolysis, immunity and pathology,” Trends in Immunology, vol. 25, no. 8, pp. 450–455, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Backes, K. F. van der Sluijs, D. P. Mackie et al., “Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review,” Intensive Care Medicine, vol. 38, no. 9, pp. 1418–1428, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. B. McMahon and H. C. Kwaan, “The plasminogen activator system and cancer,” Pathophysiology of Haemostasis and Thrombosis, vol. 36, no. 3-4, pp. 184–194, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. C. E. de Bock and Y. Wang, “Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer,” Medicinal Research Reviews, vol. 24, no. 1, pp. 13–39, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. M. R. Nijziel, R. Van Oerle, D. Hellenbrand, E. C. M. Van Pampus, H. F. P. Hillen, and K. Hamulyák, “The prognostic value of the soluble urokinase-type plasminogen activator receptor (s-uPAR) in plasma of breast cancer patients with and without metastatic disease,” Journal of Thrombosis and Haemostasis, vol. 1, no. 5, pp. 982–986, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. S. F. Shariat, C. G. Roehrborn, J. D. McConnell et al., “Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis,” Journal of Clinical Oncology, vol. 25, no. 4, pp. 349–355, 2007. View at Publisher · View at Google Scholar
  13. M. Persson, G. Östling, G. Smith et al., “Soluble urokinase plasminogen activator receptor: a risk factor for carotid plaque, stroke, and coronary artery disease,” Stroke, vol. 45, no. 1, pp. 18–23, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Sehestedt, S. Lyngbæk, J. Eugen-Olsen et al., “Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events,” Atherosclerosis, vol. 216, no. 1, pp. 237–243, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Eugen-Olsen, O. Andersen, A. Linneberg et al., “Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population,” Journal of Internal Medicine, vol. 268, no. 3, pp. 296–308, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M.-C. Alessi and I. Juhan-Vague, “PAI-1 and the metabolic syndrome: links, causes, and consequences,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 10, pp. 2200–2207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Elizondo-Montemayor, N. G. Gutierrez, D. M. Moreno, U. Martínez, D. Tamargo, and M. Treviño, “School-based individualised lifestyle intervention decreases obesity and the metabolic syndrome in Mexican children,” Journal of Human Nutrition and Dietetics, vol. 26, supplement 1, pp. 82–89, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar
  19. P. Zimmet, K. G. M. M. Alberti, F. Kaufman et al., “The metabolic syndrome in children and adolescents—an IDF consensus report,” Pediatric Diabetes, vol. 8, no. 5, pp. 299–306, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Vague, I. Juhan-Vague, M. F. Aillaud et al., “Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects,” Metabolism, vol. 35, no. 3, pp. 250–253, 1986. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Vague, I. Juhan-Vague, M. C. Alessi, C. Badier, and J. Valadier, “Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects,” Thrombosis and Haemostasis, vol. 57, no. 3, pp. 326–328, 1987. View at Google Scholar · View at Scopus
  22. B. Antuna-Puente, B. Feve, S. Fellahi, and J.-P. Bastard, “Adipokines: the missing link between insulin resistance and obesity,” Diabetes and Metabolism, vol. 34, no. 1, pp. 2–11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. R. P. Donahue, K. Rejman, L. B. Rafalson, J. Dmochowski, S. Stranges, and M. Trevisan, “Sex differences in endothelial function markers before conversion to pre-diabetes: does the clock start ticking earlier among women? The Western New York Study,” Diabetes Care, vol. 30, no. 2, pp. 354–359, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Fuhrman, “The urokinase system in the pathogenesis of atherosclerosis,” Atherosclerosis, vol. 222, no. 1, pp. 8–14, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Z. Rocha and P. Libby, “Obesity, inflammation, and atherosclerosis,” Nature Reviews Cardiology, vol. 6, no. 6, pp. 399–409, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Lyngbæk, T. Sehestedt, J. L. Marott et al., “CRP and suPAR are differently related to anthropometry and subclinical organ damage,” International Journal of Cardiology, vol. 167, no. 3, pp. 781–785, 2013. View at Publisher · View at Google Scholar · View at Scopus